Anxiety is the most common mental health condition on the planet. The World Health Organization estimates that around 301 million people were living with an anxiety disorder in 2019, making it the largest single contributor to mental health-related disability worldwide. That number represents roughly 4 percent of the global population. And because these figures come from diagnosed and reported cases, the true number is almost certainly higher.
Those estimates predate the COVID-19 pandemic, which most researchers agree pushed anxiety rates upward. A 2021 scientific brief from the WHO reported a 25 percent increase in the global prevalence of anxiety and depression during the first year of the pandemic alone. The full picture since then is still being measured.
How Many People Experience Anxiety Worldwide?
Around 301 million people were living with an anxiety disorder as of 2019, according to WHO estimates. That figure covers diagnosed anxiety disorders — not everyday worry or stress, which everyone experiences at some point.
The distinction matters. Feeling anxious before a job interview or a medical test is a normal human response. An anxiety disorder is different. It involves persistent, excessive fear or worry that interferes with daily functioning, lasts for weeks or months, and often occurs without a clear external trigger.
Anxiety disorders include generalized anxiety disorder, panic disorder, social anxiety disorder, and several phobias. Each has its own diagnostic criteria, but all involve distress or impairment that goes beyond ordinary nervousness.
It is also worth noting that these global figures are estimates built from survey data and treatment records. Many countries lack robust mental health reporting systems. Stigma prevents many people from seeking help or disclosing symptoms. So the real number is likely higher than any published estimate.
Which Regions and Populations Are Most Affected?
Anxiety disorders appear across every country, culture, and income level. But the burden is not evenly distributed.
Some research indicates that anxiety disorders are more commonly reported in high-income countries, particularly in North America and Western Europe. This may partly reflect better diagnostic infrastructure and lower stigma around mental health disclosure — not necessarily a higher true rate of illness.
In low- and middle-income countries, anxiety often goes undiagnosed. Mental health services may be scarce. Cultural norms may discourage speaking about psychological distress. When researchers use standardized screening tools rather than clinical records, the gap between high-income and low-income regions narrows considerably.
Certain populations face elevated risk regardless of geography:
- Women are diagnosed with anxiety disorders at roughly twice the rate of men, a pattern consistent across most countries studied.
- People living in conflict zones or areas affected by natural disasters show significantly higher rates.
- Individuals with chronic physical illnesses — including heart disease, diabetes, and chronic pain conditions — report anxiety at higher rates than the general population.
- Adolescents and young adults appear to be increasingly affected, though data collection methods vary across countries.
The gender difference is one of the most consistent findings in psychiatric epidemiology. It holds across cultures and age groups. Researchers have proposed hormonal, social, and reporting factors, but no single explanation has been confirmed.
Is Anxiety Becoming More Common?
The short answer is yes, at least over the past decade. But measuring change over time is harder than it sounds.
Diagnostic criteria change. Screening tools improve. Stigma decreases, which means more people report symptoms they previously hid. All of these can make prevalence appear to rise even if the underlying rate stays flat.
That said, several lines of evidence point to a genuine increase. The WHO’s 2021 brief documented a clear jump during the pandemic. Surveys of college students in multiple countries have shown rising anxiety scores over the past ten years. And emergency department visits for mental health crises involving anxiety have increased in several high-income countries.
What remains unclear is how much of this reflects a true rise in incidence versus better detection and greater willingness to seek help. Both are probably contributing.
One factor that receives less attention: economic instability. Research has linked financial insecurity, job loss, and housing instability to higher anxiety rates. During periods of widespread economic disruption, population-level anxiety tends to rise. This pattern has been observed across multiple recessions and financial crises.
What Causes Anxiety Disorders?
No single cause has been identified. Anxiety disorders emerge from a combination of genetic, biological, psychological, and environmental factors.
Genetics play a role. People with a first-degree relative who has an anxiety disorder are at higher risk themselves. But inheritance is not destiny. Many people with a family history never develop an anxiety disorder, and many without one do.
Brain chemistry is involved but not fully understood. The amygdala — a small structure deep in the brain — plays a central role in processing fear and threat. In people with anxiety disorders, this system appears to be overreactive or poorly regulated. Neurotransmitters including serotonin, norepinephrine, and GABA are involved in anxiety regulation, which is why some medications target these systems.
Life experiences matter enormously. Trauma, chronic stress, childhood adversity, and ongoing difficult circumstances all increase risk. So does substance use, which can both trigger and worsen anxiety symptoms.
Personality traits such as high neuroticism or behavioral inhibition in childhood are associated with higher risk. But these are tendencies, not predictions.
The honest position is that anxiety disorders are multifactorial. Researchers can describe the general mechanisms, but they cannot reliably predict who will develop one.
How Is Anxiety Treated?
Treatment works for many people. That is the most important thing to know.
Cognitive behavioral therapy is the most extensively studied psychological treatment for anxiety disorders. It focuses on identifying and changing the thought patterns and behaviors that maintain anxiety. Research consistently shows it produces meaningful improvement in a significant proportion of people who complete it.
Medications — particularly selective serotonin reuptake inhibitors and certain other classes — are also effective for many people. They are often prescribed alongside therapy rather than instead of it. Benzodiazepines can provide rapid short-term relief but carry a risk of dependence and are generally not recommended for long-term use.
Other approaches with some research support include:
- Exposure therapy, which gradually reduces fear responses by controlled contact with feared situations.
- Mindfulness-based stress reduction, which some studies suggest can reduce anxiety symptoms, though results vary.
- Regular physical activity, which has been associated with lower anxiety levels in observational studies.
- Sleep improvement, since sleep disruption and anxiety tend to reinforce each other.
What does not have strong evidence: most commercial supplements marketed for anxiety. Some small studies have examined certain compounds, but no supplement has been confirmed in large human trials to treat anxiety disorders effectively. Anyone considering a supplement should discuss it with a clinician, especially if they take other medications.
Access to treatment remains a major barrier worldwide. The WHO has noted that the majority of people with anxiety disorders in low- and middle-income countries receive no treatment at all. Even in high-income countries, wait times and cost prevent many people from getting care.
When Should Someone Seek Help?
The line between normal anxiety and a disorder is not always obvious. A few general guidelines can help.
Consider seeking professional support if anxiety:
- Persists for weeks or months rather than easing after a stressful event passes.
- Interferes with work, relationships, sleep, or daily activities.
- Causes physical symptoms such as rapid heart rate, shortness of breath, dizziness, or gastrointestinal distress.
- Leads to avoidance of situations that were previously manageable.
- Involves panic attacks — sudden intense fear with strong physical symptoms.
These signs do not automatically mean an anxiety disorder is present. A clinician can assess symptoms, rule out medical conditions that mimic anxiety — such as thyroid problems or heart arrhythmias — and recommend appropriate care.
Anxiety disorders are treatable. Most people who receive evidence-based treatment experience meaningful improvement. That is not a guarantee, and treatment sometimes takes time to work or requires trying more than one approach. But the evidence here is strong: therapy and medication help many people, and the earlier someone gets support, the better the outcomes tend to be.
Frequently Asked Questions
How many people have anxiety worldwide?
The WHO estimated around 301 million people were living with an anxiety disorder in 2019, about 4 percent of the global population. The true number is likely higher because many cases go undiagnosed.
Is anxiety more common in women or men?
Women are diagnosed with anxiety disorders at roughly twice the rate of men across most countries studied. Researchers have not identified a single reason for this difference.
Did anxiety increase during COVID-19?
Yes. A 2021 WHO scientific brief reported a 25 percent increase in global anxiety and depression prevalence during the first year of the pandemic. Later data continue to show elevated rates in many regions.
What percentage of people experience anxiety at some point in life?
Estimates vary by country and study method, but lifetime prevalence figures for anxiety disorders generally range from about 10 to 30 percent depending on the population studied. No single global lifetime figure is universally accepted.

